ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 767 out of 3593

$307K Total Retail Price of All Prescriptions

Rank: 1355 out of 3593

540 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 540 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 540 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,870 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 408 308 1 5
SIMVASTATIN 385 324 2 1
LEVOTHYROXINE SODIUM 381 306 3 4
LISINOPRIL 359 299 4 2
HYDROCODONE-ACETAMINOPHEN 354 184 S3 5 7
LOVASTATIN 247 214 6 20
ATENOLOL 220 175 7 11
METOPROLOL TARTRATE 213 178 8 8
FUROSEMIDE 194 161 9 9
GABAPENTIN 189 106 10 16
METFORMIN HCL 188 138 11 6
DOXAZOSIN MESYLATE 155 108 12 63
ALPRAZOLAM 128 51 13 37
HYDROCHLOROTHIAZIDE 115 106 14 10
GEMFIBROZIL 105 73 15 88
TRAMADOL HCL 101 58 16 17
BACLOFEN 99 40 17 109
PREDNISONE 98 58 18 49
AMLODIPINE BESYLATE 96 76 19 3
RANITIDINE HCL 88 40 20 27
GLIPIZIDE 83 68 21 40
THEOPHYLLINE ANHYDROUS 83 79 21 286
MELOXICAM 81 56 23 29
IBUPROFEN 80 45 24 43
OXYBUTYNIN CHLORIDE 71 68 25 104
ZOLPIDEM TARTRATE 67 49 26 12
ALENDRONATE SODIUM 66 64 27 22
WARFARIN SODIUM 65 61 28 18
DICLOFENAC SODIUM 64 50 29 74
FLUOXETINE HCL 62 29 30 60
CARISOPRODOL 61 0 R 31 97
SERTRALINE HCL 60 41 32 28
CITALOPRAM HBR 60 30 32 25
ENALAPRIL MALEATE 58 38 34 38
OXYCODONE HCL-ACETAMINOPHEN 57 21 S2 35 82
AMITRIPTYLINE HCL 55 26 R 36 90
OXYBUTYNIN CHLORIDE ER 55 50 36 175
CLONIDINE HCL 53 45 38 41
ADVAIR DISKUS 53 41 38 47
GLYBURIDE 52 40 R 40 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.